KITE

Kite Pharma, Inc.
KITE

Delisted

KITE was delisted on the 2nd of October, 2017.

0 hedge funds and large institutions have $0 invested in Kite Pharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 241 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Commonwealth Equity Services
201
Commonwealth Equity Services
Massachusetts
ZCA
202
Zeke Capital Advisors
Pennsylvania
Russell Investments Group
203
Russell Investments Group
United Kingdom
RJFSA
204
Raymond James Financial Services Advisors
Florida
B
205
Bailard
California
FPCP
206
Fort Point Capital Partners
California
BCM
207
Bayesian Capital Management
New York
FAM
208
Fortaleza Asset Management
Illinois
LTFS
209
Ladenburg Thalmann Financial Services
Florida
LP
210
LMR Partners
United Kingdom
QI
211
QS Investors
New York
SSB
212
Sandy Spring Bank
Maryland
Pacer Advisors
213
Pacer Advisors
Pennsylvania
EWM
214
Evercore Wealth Management
New York
WEC
215
Winslow Evans & Crocker
Massachusetts
GXMC
216
Global X Management Company
New York
SEI Investments
217
SEI Investments
Pennsylvania
Nisa Investment Advisors
218
Nisa Investment Advisors
Missouri
AIM
219
ARK Investment Management
Florida
HIM
220
Hillsdale Investment Management
Ontario, Canada
PNC Financial Services Group
221
PNC Financial Services Group
Pennsylvania
CGT
222
Capital Guardian Trust
California
MAM
223
Meeder Asset Management
Ohio
HI
224
Hudock Inc
Pennsylvania
Envestnet Asset Management
225
Envestnet Asset Management
Illinois